Trial intelligence / Profile preview

Pregabalin for prevention of intrathecal fentanyl-induced pruritus

IRCT20251001067462N1Phase 3Completed

Sponsor
Hormozgan University of Medical Sciences
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pregabalin in pruritus, sponsored by Hormozgan University of Medical Sciences. Started Nov 2025; status: completed.

02

Drugs

pregabalin
03

Conditions

pruritus

Beyond the preview

Go deeper on IRCT20251001067462N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20251001067462N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call